Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy

Journal of Radiation Research

Volumn 54, Issue SUPPL.1, 2013, Pages

  Habermehl, Daniel ^a   Henkner, Katrin ^a   Ecker, Swantje ^a   Jäkel, Oliver ^a   Debus, Jürgen ^a   Combs, Stephanie E ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

carbon ion therapy; fiducial marker; liver tumors; moving organs; raster scanning technique

Indexed keywords

CARBON; COMPUTERIZED TOMOGRAPHY; IONS; IRRADIATION; PHOTONS; PROTON BEAM THERAPY; RADIOTHERAPY; X RAY FILMS; X RAY RADIOGRAPHY;

CARBON ION THERAPY; FIDUCIAL MARKER; IMAGE GUIDED RADIOTHERAPY; LIVER TUMORS; MOVING ORGAN; ON BOARD IMAGING; PARTICLE THERAPY; RASTER SCANNING; RASTER-SCANNING TECHNIQUE; SCANNING TECHNIQUES;

ION BEAMS;

EID: 84880203934     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrt071     Document Type: Article

References (21)

1. Combs SE, Schulz-Ertner D, Herfarth KK et al. Advances in radio-oncology. From precision radiotherapy with photons to ion therapy with protons and carbon ions. Chirurg 2006;77:1126-32.
2. Combs SE, Ellerbrock M, Haberer T et al. Heidelberg Ion Therapy Center (HIT): Initial clinical experience in the first 80 patients. Acta Oncol 2010;49:1132-40.
3. Combs SE, Jakel O, Haberer T et al. Particle therapy at the Heidelberg Ion Therapy Center (HIT)-Integrated research-driven university-hospital-based radiation oncology service in Heidelberg, Germany. Radiother Oncol 2010;95:41-4.
4. Combs SE, Habermehl D, Ganten T et al. Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial. BMC Cancer 2011;11:67.
5. Habermehl D, Debus J, Ganten T et al. Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma-feasibility and clinical response. Radiat Oncol 2013;8:59.
6. Stieler F, Wenz F, Scherrer D et al. Clinical evaluation of a commercial surface-imaging system for patient positioning in radiotherapy. Strahlenther Onkol 2012;188:1080-4.
7. Jakel O, Reiss P. The influence of metal artefacts on the range of ion beams. Phys Med Biol 2007;52:635-44.
8. Herrmann R, Carl J, Jakel O et al. Investigation of the dosimet-ric impact of a Ni-Ti fiducial marker in carbon ion and proton beams. Acta Oncol 2010;49:1160-4.
9. Newhauser WD, Koch NC, Fontenot JD et al. Dosimetric impact of tantalum markers used in the treatment of uveal melanoma with proton beam therapy. Phys Med Biol 2007;52:3979-90.
10. Cheung J, Kudchadker RJ, Zhu XR et al. Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancer. Phys Med Biol 2010;55:7135-47.
11. Pinkawa M, Piroth MD, Holy R et al. Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer. Strahlenther Onkol 2011;187:479-84.
12. Combs SE, Haberkorn U, Debus J, Parodi K. PET-Bildgebung für die Protonen-und Schwerionentherapie: Hintergrund, Entwicklungen und klinische Implementierung. Nuklearmediziner 2011;34:93-8.
13. Bert C, Grozinger SO, Rietzel E. Quantification of interplay effects of scanned particle beams and moving targets. Phys Med Biol 2008;53:2253-65.
14. Gong GZ, Yin Y, Xing LG et al. RapidArc combined with the active breathing coordinator provides an effective and accurate approach for the radiotherapy of hepatocellular carcinoma. Strahlenther Onkol 2012;188:262-8.
15. Riboldi M, Orecchia R, Baroni G. Real-time tumour tracking in particle therapy: technological developments and future perspectives. Lancet Oncol 2012;13:e383-91.
16. Linz U. (ed) Ion beam therapy fundamentals, technology, clinical applications. In: Biological and Medical Physics, Biomedical Engineering. Berlin; New York: Springer, 2012.
17. Huang JY, Newhauser WD, Zhu XR et al. Investigation of dose perturbations and the radiographic visibility of potential fiducials for proton radiation therapy of the prostate. Phys Med Biol 2011;56:5287-302.
18. Kim JH, Hong SS, Park HJ et al. Safety and efficacy of ultrasound-guided fiducial marker implantation for CyberKnife radiation therapy. Korean J Radiol 2012;13:307-13.
19. Park JC, Park SH, Kim JH et al. Liver motion during cone beam computed tomography guided stereotactic body radiation therapy. Med Phys 2012;39:6431-42.
20. Seppenwoolde Y, Wunderink W, Wunderink-van Veen SR et al. Treatment precision of image-guided liver SBRT using implanted fiducial markers depends on marker-tumour distance. Phys Med Biol 2011;56:5445-68.
21. Schneider U, Pedroni E, Lomax A. The calibration of CT Hounsfield units for radiotherapy treatment planning. Phys Med Biol 1996;41:111-24.